mounjaro tirzepatide news What to know about UK warning on weight loss drugs' effect on birth control Big news alert! 🚨 Mounjaro

San Francisco-based biotech Structure Therapeutics (NASDAQ:GPCR) has reported Phase 2 topline results for its oral GLP-1 candidate aleniglipron, posting weight-loss outcomes the company says stack up favourably against leading next-generation drugs including Eli Lilly and Co (NYSE:LLY)s oral candidate orforglipron, which is widely expected to reach the market in the near term

With its ability to reduce melanin production and provide antioxidant benefits, glutathione stands out as an effective treatment option

Heres a look at the uses and benefits of turmeric, effective doses, and potential safety concerns

This strategy is beneficial for maximising nutrition while preventing severe side effects

Active pancreatitis or a history of pancreatitis is a contraindication

carbohydrates first) 2